Skip to main content
SpringerLink
Log in

Hypertensive Diseases in Female and Pregnancy

  • Chapter
  • First Online:
Secondary Hypertension

  • 832 Accesses

Abstract

Due to the special physical, psychological, and genetic characteristics of women, especially the different secretion and metabolism of endocrine hormones in their lifetime, the changes of blood pressure in women are different from those in men. Epidemiological data show that women’s blood pressure fluctuates with the menstrual cycle and changes with age. Studies have shown that hormones play an important role in maintaining blood pressure stability and the occurrence of hypertension in women. The main types of female hypertension include pregnancy-induced hypertension, perimenopausal hypertension, premenstrual tension syndrome hypertension, contraceptive-related hypertension, and polycystic ovary syndrome-related hypertension. The mechanism of elevated blood pressure caused by these diseases is different from that of the general population, and the epidemic characteristics are also different. Therefore, special methods should be adopted in the diagnosis, treatment, prevention, and control.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Appleton SM. Premenstrual syndrome: evidence-based evaluation and treatment. Clin Obstet Gynecol. 2018;61(1):1.

    Article  Google Scholar 

  2. Zendehdel M, Elyasi F. Biopsychosocial etiology of premenstrual syndrome: a narrative review. J Family Med Prim Care. 2018;7(2):346–56.

    Article  PubMed  PubMed Central  Google Scholar 

  3. A DM, K S, A D, Sattar K. Epidemiology of premenstrual syndrome (PMS)—a systematic review and meta-analysis study. J Clin Diagn Res. 2014;8(2):106–9.

    PubMed  Google Scholar 

  4. Qiao M, Zhang H, Liu H, Luo S, Wang T, Zhang J, et al. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China. Eur J Obstet Gynecol Reprod Biol. 2012;162(1):83–6.

    Article  PubMed  Google Scholar 

  5. Halbreich U, Borenstein J, Pearlstein T, et al. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. 2003;28(supp-S3):1–23.

    CAS  PubMed  Google Scholar 

  6. Bertone-Johnson ER, Whitcomb BW, Rich-Edwards JW, Hankinson SE, Manson JE. Premenstrual syndrome and subsequent risk of hypertension in a prospective study. Am J Epidemiol. 2015;182(12):1000–9.

    PubMed  PubMed Central  Google Scholar 

  7. Bertone-Johnson ER, Houghton SC, Whitcomb BW, Sievert LL, Zagarins SE, Ronnenberg AG. Association of premenstrual syndrome with blood pressure in young adult women. J Womens Health (Larchmt). 2016;25(11):1122–8.

    Article  Google Scholar 

  8. Rapkin AJ, Akopians AL. Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder. Menopause Int. 2012;18(2):52–9.

    Article  PubMed  Google Scholar 

  9. Nicolau ZFM, Bezerra AG, Polesel DN, et al. Plasma leptin and premenstrual syndrome. Obstet Gynecol Surv. 2017;72(11):659–62.

    Article  PubMed  Google Scholar 

  10. Elizabeth R, Bertone-Johnson S. Chronic inflammation and premenstrual syndrome: a missing link found? J Womens Health (Larchmt). 2016;25(9):857–8.

    Article  Google Scholar 

  11. Puder JJ, Blum CA, Mueller B, et al. Menstrual cycle symptoms are associated with changes in low-grade inflammation. Eur J Clin Investig. 2010;36(1):58–64.

    Article  Google Scholar 

  12. Bertone-Johnson ER, Ronnenberg AG, Houghton SC, Nobles C, Zagarins SE, Takashima-Uebelhoer BB, et al. Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women. Hum Reprod. 2014;29(9):1987–94.

    Article  CAS  PubMed  Google Scholar 

  13. Gillings MR. Were there evolutionary advantages to premenstrual syndrome? Evol Appl. 2014;7(8):897–904.

    Article  PubMed  PubMed Central  Google Scholar 

  14. del Mar Fernández M, Saulyte J, Inskip HM, et al. Premenstrual syndrome and alcohol consumption: a systematic review and meta-analysis. BMJ Open. 2018;8(3):e019490.

    Article  Google Scholar 

  15. Halbreich U, Backstrom T, Eriksson E, et al. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol. 2007;23(3):123–30.

    Article  PubMed  Google Scholar 

  16. Kaye NS, Hatters-Friedman S, Reed T, et al. Premenstrual syndrome[M]. Wiley Encyclopedia of Forensic Science. 2015.

    Google Scholar 

  17. Freeman EW, Halberstadt SM, Rickels K, et al. Core symptoms that discriminate premenstrual syndrome. J Women's Health. 2011;20(1):29–35.

    Article  Google Scholar 

  18. Talbott EO. Premenstrual syndrome and increased blood pressure: a new risk factor for cardiovascular disease in women? J Womens Health (Larchmt). 2016;25(11):1083–4.

    Article  Google Scholar 

  19. Stamatelopoulos KS, Georgiopoulos G, Papaioannou T, Lambrinoudaki I, Kouzoupis A, Vlachopoulos C, et al. Can premenstrual syndrome affect arterial stiffness or blood pressure? Atherosclerosis. 2012;224(1):170–6.

    Article  CAS  PubMed  Google Scholar 

  20. Green LJ, Panay N, Craig M. Management of premenstrual syndrome: green-top guideline no. 48. BJOG. 2017;124(3):e73–e105.

    Article  Google Scholar 

  21. O’Brien PM, Backstrom T, Brown C, Dennerstein L, Endicott J, Epperson CN, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011;14(1):13–21.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Verma RK, Chellappan DK, Pandey AK. Review on treatment of premenstrual syndrome: from conventional to alternative approach. J Basic Clin Physiol Pharmacol. 2014;25(4):319–27.

    Article  CAS  Google Scholar 

  23. Han J, Cha Y, Kim S. Effect of psychosocial interventions on the severity of premenstrual syndrome: a meta-analysis. J Psychosom Obstet Gynaecol. 2018:1–9.

    Google Scholar 

  24. Ryu A, Kim TH. Premenstrual syndrome: a mini review. Maturitas. 2015;82(4):436–40.

    Article  PubMed  Google Scholar 

  25. Verkaik S, Kamperman AM, van Westrhenen R, Schulte PFJ. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(2):150–66.

    Article  PubMed  Google Scholar 

  26. Cerqueira RO, Frey BN, Leclerc E, Brietzke E. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health. 2017;20(6):713–9.

    Article  PubMed  Google Scholar 

  27. Siahbazi S, Behboudi-Gandevani S, Moghaddam-Banaem L, Montazeri A. Effect of zinc sulfate supplementation on premenstrual syndrome and health-related quality of life: clinical randomized controlled trial. J Obstet Gynaecol Res. 2017;43(5):887–94.

    Article  CAS  PubMed  Google Scholar 

  28. Fathizadeh S, Amani R, Haghighizadeh MH, Hormozi R. Comparison of serum zinc concentrations and body antioxidant status between young women with premenstrual syndrome and normal controls: a casecontrol study. Int J Reprod Biomed (Yazd). 2016;14(11):699–704.

    CAS  Google Scholar 

  29. Mingzhou G, Dongmei G, Xiaoqin L, Hui S, Mingqi Q. Research progress on etiology, pathogenesis and treatment of prepubertal PMS. 2016; 36(2):251–255.

    Google Scholar 

  30. Lukes AS, McBride RJ, Herring AH, Fried M, Sherwani A, Dell D. Improved premenstrual syndrome symptoms after NovaSure endometrial ablation. J Minim Invasive Gynecol. 2011;18(5):607–11.

    Article  PubMed  Google Scholar 

  31. Nichols HB, Trentham-Dietz A, Hampton JM, et al. From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol. 2006;164(10):1003–11.

    Article  PubMed  Google Scholar 

  32. Hua C, You-Ji F, Hui-Min S. Survey on menopausal age and menstruation span in women in Pudong district of Shanghai. Chin J Obstet Gyneol. 2010;45(6):415–9.

    Google Scholar 

  33. Shen Cai E, Lu S, Chaoyun R. Investigation on perimenopausal symptoms and health care knowledge needs of perimenopausal women in Suzhou. Chinese Clin Study. 2013;26(10):1136–7.

    Google Scholar 

  34. Yang ZJ, Liu J, Ge JP, et al. Prevalence of cardiovascular disease risk factor in Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. Eur Heart J. 2012;33(2):213–20.

    Article  PubMed  Google Scholar 

  35. Dubey RK, Imthurn B, Zacharia LC, Jackson EK. Hormone replacement therapy and cardiovascular disease: what went wrong and where do we go from here? Hypertension. 2004;44:789–95.

    Article  CAS  PubMed  Google Scholar 

  36. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol. 2004;286:R233–49.

    Article  CAS  PubMed  Google Scholar 

  37. Ağan K, Özmerdivenli R, Değirmenci Y, et al. Evaluation of sleep in women with menopause: results of the Pittsburg Sleep Quality Index and polysomnography. J Turkish German Gynecol Assoc. 2015;16(3):149–52.

    Article  Google Scholar 

  38. Hua Jun X, Lan XF, Li QY, Zhou LN, et al. Factors affecting blood pressure profile in pre and postmenopausal women with obstructive sleep apnea hypopnea syndrome. Sleep Breath. 2015;19(1):169–74. https://doi.org/10.1007/s11325-014-0983-z.

    Article  Google Scholar 

  39. BaHammam AS, Pandi-Perumal SR, Piper A, et al. Gender differences in patients with obesity hypoventilation syndrome. J Sleep Res. 2016;25(4):445–53. https://doi.org/10.1111/jsr.12400.

    Article  PubMed  Google Scholar 

  40. Chen Y. Perimenopausal hypertension. Chinese J Cardiovasc Cerebrovasc Diseases Elderly. 2017;19(6):670–2.

    Google Scholar 

  41. Lisheng L, Zhaosu W, et al. Chinese guidelines for prevention and treatment of hypertension—a report of the revision committee of Chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2019;16(3):182–241.

    Google Scholar 

  42. Harlow SD, et al. EXECUTIVE SUMMARY of STRAW+10: addressing the unfinished agenda of staging reproductive aging. Climacteric. 2012;15(2):105–14.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Jie L. Obstetrics and gynecology. 7th ed. Beijing: People’s Medical Publishing House; 2005.

    Google Scholar 

  44. Yu Q. Peri-menopausal and postmenopausal hormone therapy. Chinese J Clin. 2008;2:499–502.

    Google Scholar 

  45. de Villiers TJ, Hall JE, Pinkerton JV, Cerdas Pérez S, Rees M, Yang C, Pierroz DD. Revised global consensus statement on menopausal hormone therapy. Maturitas. 2016;91:153–5.

    Article  PubMed  Google Scholar 

  46. Women′s Health Work Group in Chinese Society of Cardiology. Expert consensus for the prevention of cardiovascular disease in Chinese women Committee of Women Physician in Chinese College Cardiovascular Physicians. Chin J Intern Med. 2017;56(06):472–6.

    Google Scholar 

  47. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation. 2011;123(11):1243–62.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Women’s Health Work Group in Chinese Society of Cardiology. Expert consensus for the prevention of cardiovascular disease in Chinese women Committee of Women Physician in Chinese College Cardiovascular Physicians. Chin J Card Review. 2012;10(5):321–5.

    Google Scholar 

  49. Bolland ML, Ames RW, Horne AM, et al. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int. 2007;18(4):479–86.

    Article  CAS  PubMed  Google Scholar 

  50. Ping Q, Guixiang H. Research progress of Chinese and western medicine on perimenopausal syndrome. J Changchun Univ Chinese Med. 2010;26(5):789–91.

    Google Scholar 

  51. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol. 2002;100(2):369–77.

    PubMed  Google Scholar 

  52. Gilbert WM, Young AL, Danielsen B. Pregnancy outcomes in women with chronic hypertension: a population_based study. J Reprod Med. 2007;52(11):1046–51.

    PubMed  Google Scholar 

  53. Brown MA, Mageec LA, et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291–310.

    Article  CAS  PubMed  Google Scholar 

  54. Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med. 2009;122:890.

    Article  PubMed  Google Scholar 

  55. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol. 2000;95:24.

    CAS  PubMed  Google Scholar 

  56. Buchbinder A, Sibai BM, Caritis S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol. 2002;186:66.

    Article  PubMed  Google Scholar 

  57. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785–99.

    Article  PubMed  Google Scholar 

  58. ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019; 133:e1.

    Google Scholar 

  59. Sibai BM, El-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986;155:1011.

    Article  CAS  PubMed  Google Scholar 

  60. van Rijn BB, Hoeks LB, Bots ML, et al. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol. 2006;195:723.

    Article  PubMed  Google Scholar 

  61. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol. 1991;165:1408.

    Article  CAS  PubMed  Google Scholar 

  62. Gaugler-Senden IP, Berends AL, de Groot CJ, Steegers EA. Severe, very early onset preeclampsia: subsequent pregnancies and future parental cardiovascular health. Eur J Obstet Gynecol Reprod Biol. 2008;140:171.

    Article  PubMed  Google Scholar 

  63. Butalia S, et al. Hypertension Canada’s 2018 guidelines for the management of hypertension in pregnancy. Canadian J Cardiovasc. 2018;34:526–31.

    Article  Google Scholar 

  64. Ahmed A. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications. Thromb Res. 2011;127(Suppl. 3):S72–5.

    Article  CAS  PubMed  Google Scholar 

  65. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078–82.

    CAS  PubMed  Google Scholar 

  66. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999;84:4006–11.

    Article  CAS  PubMed  Google Scholar 

  67. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol. 1999;51:779–86.

    Article  CAS  Google Scholar 

  68. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–8.

    PubMed  Google Scholar 

  69. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745–9.

    Article  CAS  PubMed  Google Scholar 

  70. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544–51.

    Article  PubMed  Google Scholar 

  71. Zhuang J, Liu Y, Xu L, Liu X, Zhou L, Tang L, Kang D, Guo W, He M, Yang F, et al. Prevalence of the polycystic ovary syndrome in female residents of Chengdu. China Gynecol Obstet Invest. 2014;77:217–23.

    Article  PubMed  Google Scholar 

  72. Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–55.

    Article  PubMed  Google Scholar 

  73. Endocrinology and Metabolism Branch of Chinese Medical Association. Expert consensus on diagnosis and treatment of polycystic ovary syndrome. Chin J Endocrinol Metab. 2018;34(1):1–7.

    Google Scholar 

  74. Rutkowska AZ, Diamanti-Kandarakis E. Polycystic ovary syndrome and environmental toxins. Fertil Steril. 2016;106(4):948–58. https://doi.org/10.1016/j.fertnstert.2016.08.031.

    Article  CAS  PubMed  Google Scholar 

  75. Sedighi S, Amir Ais Akbari S, Afrakhteh M, et al. Comparison of lifestyle in women with polycystic ovary syndrome and healthy women. Glob J Health Sci. 2014;7(1):228–34.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Xita N, Tsatsoulis A. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab. 2006;91(5):1660–6.

    Article  CAS  PubMed  Google Scholar 

  77. Joham AE, Palomba S, Hart R. Polycystic ovary syndrome, obesity, and pregnancy. Semin Reprod Med. 2016;34(2):93–101.

    Article  PubMed  Google Scholar 

  78. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148–59.

    Article  CAS  PubMed  Google Scholar 

  79. Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618–37.

    Article  CAS  PubMed  Google Scholar 

  80. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–36.

    Article  CAS  PubMed  Google Scholar 

  81. Hahn S, Tan S, Elsenbruch S, et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res. 2005;37(7):438–44. https://doi.org/10.1055/s-2005-870236.

    Article  CAS  PubMed  Google Scholar 

  82. Jie Q, Rong L, Li L, et al. Epidemiological study of polycystic ovary syndrome. Chinese J Pract Gynecol Obstet. 2013;29(11):849–52.

    Google Scholar 

  83. Brzozowska MM, Ostapowicz G, Weltman MD. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. J Gastroenterol Hepatol. 2009;24(2):243–7.

    Article  CAS  PubMed  Google Scholar 

  84. Cai J, Wu CH, Zhang Y, et al. High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance. Int J Obes. 2017;41(9):1341–7.

    Article  CAS  Google Scholar 

  85. Shi Y, Cui Y, Sun X, et al. Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors. Eur J Obstet Gynecol Reprod Biol. 2014;173:66–70.

    Article  PubMed  Google Scholar 

  86. The Royal College of Obstetricians and Gynaecologists. Long-term consequences of polycystic ovary syndrome. RCOG Green-top Guideline. 2014;31:1–15.

    Google Scholar 

  87. American College of Obstetricians and Gynecologists. Polycystic ovary syndrome. Wolters Kluwer Health. 2018;101(6):157–71.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Center of Hypertension of People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China

    Delian Zhang, Xiaotong Wang, Jiao Qu, Yuanyuan Li, Tian Shi & Weiwei Zhang

Authors
  1. Delian Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaotong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiao Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuanyuan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tian Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Weiwei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Center of Hypertension of People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China

    Nanfang Li

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zhang, D., Wang, X., Qu, J., Li, Y., Shi, T., Zhang, W. (2020). Hypertensive Diseases in Female and Pregnancy. In: Li, N. (eds) Secondary Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-15-0591-1_17

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0591-1_17

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0590-4

  • Online ISBN: 978-981-15-0591-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation